The prognostic value of CD44 isoform expression in endometrial cancer

British Journal of Cancer

Volumn 77, Issue 7, 1998, Pages 1137-1139

  Tempfer, C ^a   Haeusler, G ^a   Kaider, A ^a   Hefler, L ^a   Hanzal, E ^a   Reinthaller, A ^a   Breitenecker, G ^a   Kainz, Ch ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adhesion molecule; Endometrium; Neoplasm; Prognosis

Indexed keywords

CD44V ANTIGEN; CELL ADHESION MOLECULE; HERMES ANTIGEN; MEMBRANE PROTEIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CELL ADHESION; CONTROLLED STUDY; ENDOMETRIUM CANCER; EXON; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; SURVIVAL TIME; TUMOR CELL; TUMOR DIFFERENTIATION;

EID: 0031929916     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.188     Document Type: Article

References (23)

1. Behzad F, Seif W, Campbell S and Aplin JD (1994) Expression of two isoforms of CD44 in human endometrium. Biol Reprod 51: 739-747
2. Charpin C, Garcia S, Bouvier C, Devictor B, Andrac L, Choux R, Lavaut MN and Allasia C (1997) Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas. Hum Pathol 28: 289-296
3. Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P and Ponta H (1995) Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 60: 471-477
4. Figge J, Del-Rosario AD, Gerasimov G, Dedov I, Bronstein M, Troshina K, Alexandrovna G, Kallakury BV, Bui HX and Bratslavsky G (1994) Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma. Exp Mol Pathol 61: 203-211
5. Fujita N, Yaegashi N, Ide Y, Sato S, Nakamura M, Ishiwata I and Yajima A (1994) Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD-44 in lymph-vascular space involvement of cancer cells. Cancer Res 54: 3922-3928
6. Gallup DG and Stock RJ (1984) Adenocarcinoma of the endometrium in women 40 years of age or younger. Obs Gyn 64: 417-423
7. Hermanek P and Sobin LH (1992) UICC TNM Classification of Malignant Tumours. 4th edn. Springer: Berlin
8. Jalkanen S, Joensuu H, Soderstrom KO and Klemi P (1991) Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J Clin Invest 87: 1835-1840
9. Joensuu H, Ristamaki R, Klemi PJ and Jalkanen S (1993a) Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. Br J Cancer 68: 428-432
10. Joensuu H, Klemi PJ, Toikkanen S and Jalkanen S (1993b) Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 143: 867-874
11. Kainz C, Kohlberger P, Sliutz G, Tempfer C, Heinzl H, Reinthaller A, Breitenecker G and Koelbl H (1995) Splice variants of CD44 in human cervical cancer stage IB to IIB. Gynecol Oncol 57: 383-387
12. Kaufmann M, Heider KH, Sinn HP, von-Minckwitz G, Ponta H and Herrlich P (1995) CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615-619
13. Komminoth P, Seelentag W, Saremaslani P, Heitz PU and Roth J (1996) CD44 isoform expression in the diffuse neuroendocrine system - benign and malignant tumors. Histochem Cell Biol 106: 551-562
14. Malviya VK, Deppe G, Malone JM, Sundareson AS and Lawrence WD (1989) Reliability of frozen section examination in identifying poor prognostic indicators in stage I endometrial adenocarcinoma. Gynecol Oncol 34: 299-304
15. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD and Graham JE (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40: 55-65
16. Salmi M, Gron-Virta K, Sointu P, Grenman R, Kalimo H and Jalkanen S (1993) Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumours of squamocellular origin. J Cell Biol 122: 431-442
17. Sliutz G, Tempfer C, Winkler S, Kohlberger P, Reinthaller A and Kainz C (1995) Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Br J Cancer 72: 1494-1497
18. Stamenkovic I, Aruffo A, Amiot M and Seed B (1991) The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10: 343-348
19. Tanabe KH and Saya H (1994) The CD44 adhesion molecule and metastasis. Crit Rev Oncog 5: 201-212
20. Tempfer C, Gitsch G, Haeusler G, Reinthaller A, Koelbl H and Kainz C (1996) Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva. Cancer 78: 273-277
21. Uhl-Steidl M, Mueller-Holzner E, Zeimet AG, Adolf GR, Daxenbichler G, Marth C and Dapunt O (1995) Prognostic value of CD44 splice variant expression in ovarian cancer. Oncology 52: 400-406
22. Wielenga VJM, Heider KH, Offerhaus JA, Adolf GR, van den Berg FM, Ponta H, Herrlich P and Pals ST (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754-4756
23. Yaegashi N, Fujita N, Yajima A and Nakamura M (1995) Menstrual cycle dependent expression of CD44 in normal human endometrium. Hum Pathol 26: 862-865